Navigation Links
Yongye Biotechnology International Announces Second Quarter Results
Date:8/18/2008

BEIJING, Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced its financial results for the quarter ended June 30, 2008.

Second Quarter 2008 Highlights

-- Revenue was $17.6 million, an increase of 136.6% from the second

quarter of 2007, and an increase of 87.0% from the first quarter of

2008

-- Gross profit was $9.6 million, a 171.8% increase from the second

quarter of 2007, with a gross margin of 54.5%

-- Net income was $7.2 million, an increase of 116.2% from the second

quarter of 2007, or $0.41 per diluted share

-- Completed a share exchange transaction to become a publicly traded

company in April 2008

-- Raised $10.0 million gross proceeds through a private placement

financing in April 2008

Second Quarter 2008 Financial Results

"The second quarter of the year is typically our strongest quarter for sales of plant and animal nutrient products, and this year's second quarter had exceptionally good results, with both revenue and earnings more than doubling from the prior year period," said Mr. Zishen Wu, Chief Executive Officer of Yongye. "We attribute this to the very strong benefits our customers are able to gain from the use of our technologically advanced products and the rapid expansion of our distribution network to cover new geographic regions and build strong brand recognition for our products."

Second Quarter 2008 Results

Revenue was $17.6 million in the second quarter of 2008, an increase of 136.6% from $7.4 million in the second quarter of 2007. This significant revenue increase was due mainly to the rapid expansion of the Company's sales network. An additional 425 branded stores were added to the distribution n
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
4. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. New Book on the Business of Biotechnology
7. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
8. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Pennsylvania Governor Rendell Says State Number 1 in New Biotechnology Study
11. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...wire/ -- The Burrill Biotech Select Index managed ...ber. The Select,s gain of 4.5 percent mirrored wha...ets with the Dow up 6.5 percent and the NASDAQ up ...inal two trading days of the month despite investo...ping and Dubai,s reported debt woes. ,, Almost ...
(Date:12/1/2009)...day announced a collaborative research agreement w...aluating EpiVax’s proprietary Tregitope tech... immune responses to certain drugs. In the course ...itope technology will be evaluated for its effect ..., (Vocus) December 2, 2009...
(Date:12/1/2009)...swire-FirstCall/ -- Palatin Technologies, Inc. (NY...nt and Trademark Office has issued U.S. Patent No....structs." The claims in the issued patent cover a...ic peptide receptor A (NPRA), including PL-3994, P..."Our natriuretic compounds, including PL-3994, add...
(Date:12/1/2009)...lifornia and AMSTERDAM, December 1 ...ostics, announced today that,Palmetto GBA, Califor...ed,coding guidelines for the company,s MammaPrint ...ancer recurrence test, which has been reimbursed b...e United States can now submit claims for the,Mamm...
Breaking Biology Technology:Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...wswire-Asia-FirstCall/ -- China Sky One Medical,In...daq: CSKI ), a leading,fully integrated pharmace...,the People,s Republic of China ("PRC"), announced...sident of China Sky One Medical took part in an,in...erspective. , As a well-known pharmaceutical...
...vation, Inc.,(Nasdaq: MDVN ) today announced tha...officer, will be a featured speaker on two panels ...nce on Thursday, December 11, in New York: , ...5 a.m. Eastern Time, -- "The Challenge of Alzhe... Time, , A live audio webcast of each pane...
...icient Construction of Synthetic Genomes , , ...ig Venter Institute (JCVI), a not-for-profit genom...escribing a significant advance in genome assembly...erial genome, Mycoplasma genitalium, in one step...ibson, Ph.D. and his team published their results ...
Other Biology Technology:China Sky One Medical, Inc. Interviewed in The China Perspective 2China Sky One Medical, Inc. Interviewed in The China Perspective 3Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 2J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 3J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 4J. Craig Venter Institute Researchers Publish Significant Advance in Genome Assembly Technology 5
(Date:12/1/2009)... The Georgia Institute of Technology has been awa...gn nanostructures for energy harvesting and adapti...tical cognitive processes of the modern warfighter...nano-enabled Inorganic/Organic Nanostructures and ...y Vladimir Tsukruk and Kenneth Sandhage, professor...
(Date:12/1/2009)...GAINESVILLE, Fla. Hit-and-run attacks by sharks c...the culprits by the unique chomp they put on their...earcher and shark expert. , In a method analogou...make identifications by precisely comparing shark ...ors, said George Burgess, director of the Internat...
(Date:12/1/2009)... , RICHLAND, Wash. -- Time-lapsed video of indivi...en event in the life of a cell: a protein that cyc...e results give researchers a more complete view of...ls to grow, events that go awry in cancer and are ... which helps cells respond to growth factors, trav...
Breaking Biology News(10 mins):Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 1Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 1Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 3Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 4PATHFAST 28R 29 Rapid Whole Blood Immunoassay Analyzer from Polymedco 49913 1PATHFAST 28R 29 Rapid Whole Blood Immunoassay Analyzer from Polymedco 49913 2
...ecial stretch of genetic material may turn off the... cancer with a vaccine, said researchers at Baylor...rt in today,s issue of the journal Science, Dr. Ro... and Gene Therapy and Department of Immunology, an...ff the function of a special group of T cells to s...
...ntists in the UK have proved that human embryonic ...early forms of cells that eventually become eggs o...eggs and sperm could be grown from stem cells and ...g and the creation of more stem cells for further ...nts suffering from a range of diseases. , Behrouz ...
...ltinational team of researchers has grown new musc...in the laboratory, and implanted the new muscle in... tissue engineering, according to a report in the ...archer Dr. Shulamit Levenberg of the Technion-Isra...from the Massachusetts Institute of Technology, gr...
Other Biology News:Improving the potential of cancer vaccines 2Human embryonic stem cells have the potential to develop into eggs and sperm in the laboratory 2Human embryonic stem cells have the potential to develop into eggs and sperm in the laboratory 3New complete muscle grown in the lab 2
Human Granzyme B ELISPOT Kit from DiaPharma Group, Inc.
Rat Caspase-3 Active from BioVision
Mouse Anti-Rat KAPPA / LAMBDA Monoclonal Antibody, Horseradish Peroxidase Conjugated, Clone MARK-1 / MARL-15 from Cell Sciences
MagCellect Rat CD4+ T Cell Isolation Kit from R&D Systems
Biology Products: